NCT02054520 2023-04-18Immunotherapy Study for Patients With Stage IV MelanomaLumos PharmaPhase 2 Terminated47 enrolled 16 charts
NCT00101166 2018-02-28Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed43 enrolled 6 charts